- $17.88m
- $18.87m
- $1.01m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 35.76 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -398.78% | ||
| Operating Margin | -3156.2% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | 1.01 | 15.5 | 30.5 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Corvex, Inc., formerly Movano Inc., is an artificial intelligence (AI) cloud computing company. The Company specializes in graphics processing unit (GPU)-accelerated infrastructure for AI workloads. The Company’s products include GPU Clusters, Inference as a Service, Confidential Computing, and GPU Node. Its solutions are AI Model Builders, Enterprises and Federal and Sovereign. Its AI factories and GPU clusters are an integrated computing and data-center platform, which is designed to deliver artificial intelligence workloads at scale by combining high-performance AI accelerators, networking, power, cooling, and systems software to support AI training and inference. Its Confidential Computing is designed to protect customers' intellectual property and enhance compliance with data security mandates. Its Inference as a service is the fully managed delivery of model inference-service level agreements (SLAs), autoscaling, observability, and security included.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- September 30th, 2025
- Incorporated
- January 30th, 2018
- Public Since
- March 23rd, 2021
- No. of Shareholders
- 305
- No. of Employees
- 32
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 1,208,857
- Address
- 6800 Koll Center Parkway, PLEASANTON, 94566
- Web
- https://movanohealth.com/
- Phone
- +1 3026365400
- Auditors
- MOSS ADAMS LLP
Upcoming Events for MOVE
Q4 2025 Movano Inc Earnings Release
Q1 2026 Movano Inc Earnings Release
Q2 2026 Movano Inc Earnings Release
Similar to MOVE
20/20 Biolabs
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the Corvex, share price?
As of Today at 01:06 UTC, shares in Corvex, are trading at $14.79. This share price information is delayed by 15 minutes.
How has the Corvex, share price performed this year?
Shares in Corvex, last closed at $14.79 and the price had moved by -27.14% over the past 365 days. In terms of relative price strength the Corvex, share price has underperformed the S&P500 Index by -35.96% over the past year.
What are the analyst and broker recommendations for Corvex,?
The overall consensus recommendation for Corvex, is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Corvex, dividend yield?
Corvex, does not currently pay a dividend.
Does Corvex, pay a dividend?
Corvex, does not currently pay a dividend.
When does Corvex, next pay dividends?
Corvex, does not currently pay a dividend.
How do I buy Corvex, shares?
To buy shares in Corvex, you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Corvex,?
As of the previous close price of $14.79, shares in Corvex, had a market capitalisation of $17.88m.
Where are Corvex, shares listed?
Here are the trading details for Corvex,:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: MOVE
What kind of share is Corvex,?
Based on an overall assessment of its quality, value and momentum Corvex, is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Corvex, share price forecast for 2026?
The analyst consensus target price for shares in Corvex, is $30.00. That is 102.84% above the last closing price of $14.79.
Analysts covering Corvex, currently have a consensus Earnings Per Share (EPS) forecast of -$28.00 for the next financial year.
Find out moreWhat is the trend in the Corvex, share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Corvex,. Over the past six months, its share price has outperformed the S&P500 Index by +174.36%.
As of the last closing price of $14.79, shares in Corvex, were trading +66.67% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Corvex, PE Ratio?
The Corvex, PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $14.79.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Corvex,?
Corvex,'s management team is headed by:
- John Mastrototaro - CEO
- Michael Leabman - FDR
- J. Cogan - CFO
- Phil Kelly - VPR
- Brian Cullinan - DRC